OPT - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים Opthea Corp

The year-over-year sales growth percentage (over 4 quarters) for Opthea Limited (OPT) on GURU.Markets illustrates revenue dynamics, where 0.00 records a new level, correlating with the success of VEGF-C/D protein blocker therapy for macular dystrophy. The business foundation relies on precise cross-border cold-chain logistics for biologics. Capital stability guarantees an autonomous product cycle that remains independent of global economic shocks.

This indicator assesses revenue dynamics over the last twelve months relative to the previous year, allowing investors to promptly adjust income expectations and avoid value traps. By analyzing year-over-year sales growth (TTM), one can evaluate how the automation of data collection in clinical trials at Opthea Limited (OPT) impacts the operational efficiency and commercial scalability of its ophthalmology developments.